Ceftolozane–tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3, non-inferiority trial
Titel:
Ceftolozane–tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3, non-inferiority trial
Auteur:
Kollef, Marin H Nováček, Martin Kivistik, Ülo Réa-Neto, Álvaro Shime, Nobuaki Martin-Loeches, Ignacio Timsit, Jean-François Wunderink, Richard G Bruno, Christopher J Huntington, Jennifer A Lin, Gina Yu, Brian Butterton, Joan R Rhee, Elizabeth G